D.R. Horton Inc. (0I6K)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 146.55 |
|---|---|
| 52-week range | 130.03 – 170.12 |
| Return, 1 month / 3 months | +1.9% / +3.6% |
| Return, 1 year / 3 years | −6.8% / +49.1% |
| Trend | Below its 200-day average |
| RSI (14) | 62 |
| Volatility (1 year) | 34.8% |
| Worst drawdown (1 year) | -21.4% |
| Average daily value traded | 0.12M USD |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
D.R. Horton Inc. is an American homebuilding company based in Texas. It designs, builds and sells single-family homes and attached homes in communities across the United States, serving first-time buyers, move-up buyers and active adults. Through its subsidiaries it also offers mortgage financing, title and insurance services to homebuyers. The company operates in many local housing markets and sells its homes directly to individual customers rather than to businesses.
On this site D.R. Horton Inc. appears as a stock on the London Exchange (UK), code 0I6K, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
D.R. Horton Inc. (0I6K) trades on the London Exchange in UK. It last closed at USD 146.55 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,187 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.8% and over the last three months it rose 3.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -0.5% | ||
| From 52-week high | -12.7% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 3.6% | ||
| 6-month return | -8.8% | ||
| 12-month return, skipping the last month | -8.5% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.4% | ||
| Liquidity | 32 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.12M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.8% |
|---|---|
| 1 month | +1.9% |
| 3 months | +3.6% |
| 6 months | −8.8% |
| 1 year | −6.8% |
| 3 years | +49.1% |
| 5 years | +72.2% |
Signals
| 50-day / 200-day average | 141.24 / 147.36 |
|---|---|
| Golden / death cross (60 days) | Death, 32 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.60 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Aug 2026 | USD 0.4500 |
| 6 May 2026 | USD 0.4500 |
| 4 Feb 2026 | USD 0.4500 |
| 12 Nov 2025 | USD 0.4500 |
| 6 Aug 2025 | USD 0.4000 |
| 2 May 2025 | USD 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.